The new drug packaging facility in the city of Kostroma will now locally handle packaging of medications for a wide range of illnesses, such as rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, juvenile idiopathic arthritis, ankylosing spondylitis, and plaque psoriasis. R-Pharm is the name of the new packaging plant, which is launched in partnership with the pharmaceutical manufacturer AbbVie from the United States. Most of the drugs packaged at the facility are aimed at treating the disorders of the immune system. AbbVie’s marketing strategy includes higher localization of its products.

AbbVie is a relatively young company on the biopharmaceuticals market. It was established in January of 2013 and now has operations in 170 countries of the world. The reported yearly revenue of the company is estimated at USD18 billion. The company supplies traditional lines of medications, including drugs for rheumatoid arthritis, psoriasis, Crohn’s disease, HIV/ AIDS, and other auto-immune disorders. In addition to traditional items, AbbVie offers new drug brands.

R-Pharm is a Russian company specializing in medical innovations, the development of new drugs, conducting research in the medical field, and brining medications to the market. In 2012, R-Pharm’s turnover from operations within Russia and the C.I.S. was recorded at USD1.8 billion.